Alopecia News and Research

RSS

Alopecia is the lack or loss of hair from areas of the body where hair is usually found. Alopecia can be a side effect of some cancer treatments.

Ingenza collaborates with Amplifica to advance novel alopecia treatments

Industrial biotech specialist Ingenza is delighted to announce that it is collaborating with clinical-stage biopharmaceutical company Amplifica Holdings Group, Inc. to develop an innovative treatment to address androgenic alopecia.

From Ingenza Ltd 23 Jan 2023

Study links sugary drinks to male hair loss

A new Nutrients journal study explored the association between sugar-sweetened beverage (SSB) consumption and MPHL in young men in China.

4 Jan 2023

Can prostaglandin E2 injection improve hair growth?

A new study demonstrated that prostaglandin E2 (PGE2) stimulates hair follicle growth.

9 Nov 2022

Researchers use AI to predict compounds that could neutralize baldness

Hair loss is undesirable for many men -; and women -; because one's hairstyle is often closely tied to their self-confidence.

31 Oct 2022

Researchers successfully generate fully mature hair follicles in cultures

A team of researchers from Japan studying the processes of hair follicle growth and hair pigmentation has successfully generated hair follicles in cultures.

21 Oct 2022

Are men or women impacted more by adverse reactions to prescription drug treatments?

Recently, researchers presented an overview of sex-based differences in adverse drug reactions (ADRs) based on epidemiology, technique, and underlying mechanism data.

11 Oct 2022

Survey: 'Healthy tan' and other myths about sun safety are alive in Europe, other countries

8 in 10 Europeans believe tans are attractive with almost as many (73%) saying tans are healthy, according to a new study presented today at the 31st European Academy of Dermatology and Venereology (EADV) Congress.

9 Sep 2022

Does COVID-19 cause hair loss?

A new study discusses hair loss as a result of COVID-19.

12 Jul 2022

New signaling molecule may offer a therapeutic treatment for common form of hair loss

University of California, Irvine-led researchers have discovered that a signaling molecule called SCUBE3 potently stimulates hair growth and may offer a therapeutic treatment for androgenetic alopecia, a common form of hair loss in both women and men.

30 Jun 2022

The link between androgens and COVID-19

A new paper examines the association between androgens and COVID-19, as revealed by the research carried out on this topic throughout the pandemic.

20 May 2022

Systematic review with meta-analysis of the current evidence regarding the incidence of long COVID symptomatology

The researchers searched several databases looking for observational studies on the incidence of long COVID symptoms and signs by organ system, based on the World Health Organization (WHO) criteria.

10 May 2022

Mount Sinai Health System launches new Alopecia Areata Center of Excellence

In an unparalleled effort to deliver outstanding comprehensive care and to employ revolutionary approaches to novel therapeutics around the skin condition alopecia areata, the Mount Sinai Health System has launched the Alopecia Areata Center of Excellence.

21 Mar 2022

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

The study, published on the pre-print server medRxiv*, analyzed the specific linkages between the COVID-19 patients belonging to the three risk groups with the overall COVID-19 patients and compared symptoms between and within the risk groups.

6 Dec 2021

Chemotherapy Patients Benefit from Optimum Coolant Flow During Treatment

Titan Enterprises celebrates over 10 years of partnership development with Paxman Coolers Ltd (www.paxmanscalpcooling.com) as the company reports over 4,000 Paxman scalp-cooling systems are now installed around the world, reducing the likelihood of chemotherapy-induced alopecia.

From Titan Enterprises Ltd 15 Oct 2021